Evaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT07054736 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07054736
- Sponsor
- Zhejiang Kanova Biopharmaceutical Co., LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-31
- Primary completion
- 2025-10-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.